Please select the option that best describes you:
In light of Aizer et al. data presented at ASCO 2025, what is your threshold for offering SRS/SRT in patients with multiple brain metastases?
Answer from: Radiation Oncologist at Academic Institution
In light of the Aizer et al., ASCO, 2025 data presented at ASCO 2025 and at NRG recently—a multicenter phase 3 randomized trial comparing stereotactic radiation to hippocampal avoidance whole-brain radiation therapy (HA-WBRT) in patients with 5–20 brain metastases—I am increasingly...
Sign in or Register to read more